You may need to flick it several times, until all the air rises to the top
Clinical Decision-Making Framework When considering BPC-157 therapy, evaluate: Severity and chronicity of the inflammatory condition Response to conventional first-line therapies Patient-specific factors including goals, expectations, and financial considerations Availability of evidence supporting use in the specific condition Potential for integration into comprehensive treatment approach BPC-157 is best positioned as adjunctive therapy or alternative option when conventional approaches have proven insufficient, rather than as first-line treatment for most inflammatory conditions
Indications: In disorders requiring parenteral administration of vitamins, that is, pre- and postoperative treatment, when requirements increase as in fever, severe burns, increased metabolism, pregnancy, gastrointestinal disorders that interfere with the intake or absorption of vitamins, diseases prolonged or debilitating, alcoholism and where other deficiencies exist
Much of the purported clinical utility is derived from anecdotal accounts or small, uncontrolled series, rather than from robust randomized trials
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY)
This pathway is considered to promote cell migration and adhesion, especially in tendon fibroblasts